RIGEL PHARMACEUTICALS INC (RIGL) Stock Cash Flow
NASDAQ:RIGL - Nasdaq - US7665597024 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 37.18M | 17.48M | -25.09M | -58.57M | -17.91M | |||
| Depreciation Amortization | 2.43M | 2.23M | 1.24M | 1.00M | 1.16M | |||
| Change In Working Capital | -13.83M | 153.00K | 9.52M | -29.05M | 9.72M | |||
| Interest Paid | 7.01M | 7.04M | 5.85M | 2.50M | 1.50M | |||
| Taxes Paid | N/A | 331.00K | N/A | N/A | 1.50M | |||
| Other non cash items | 9.81M | 11.61M | 8.59M | 12.87M | 12.91M | |||
| OPERATING CASH FLOW | 35.59M | 31.47M | -5.74M | -73.76M | 5.88M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -396.00K | -15.00M | -450.00K | -630.00K | |||
| Other Investing Activity | -6.48M | 4.53M | 10.70M | 73.23M | -79.41M | |||
| INVESTING CASH FLOW | -6.74M | 4.13M | -4.30M | 72.78M | -80.04M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 0.00 | 0.00 | 19.95M | 19.54M | 0.00 | |||
| Stock Issued/Repurchased | 2.36M | 1.96M | 1.05M | 2.12M | 4.78M | |||
| Other Financing Activity | N/A | -13.61M | -2.63M | -15.12M | 57.90M | |||
| FINANCING CASH FLOW | -8.64M | -11.64M | 18.37M | 6.55M | 62.68M | |||
| CHANGE IN CASH | 20.21M | 23.96M | 8.33M | 5.57M | -11.48M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 35.59M | 31.47M | -5.74M | -73.76M | 5.88M | |||
| Capital Expenditure | N/A | -396.00K | -15.00M | -450.00K | -630.00K | |||
| FREE CASH FLOW | 35.33M | 31.07M | -20.74M | -74.21M | 5.25M | |||
All data in USD